REDOXOPHORE

USPTO USPTO 2002 ABANDONED - NO STATEMENT OF USE FILED

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark REDOXOPHORE was filed as Word mark on 01/03/2002 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".

Trademark Details Last update: May 19, 2018

Trademark form Word mark
File reference 76354629
Application date January 3, 2002
Publication date January 7, 2003

Trademark owner

5301 Patrick Henry Drive
95054 Santa Clara
US

Trademark representatives

goods and services

1 chemical additives for use in the manufacture of pharmaceuticals, skin care preparations, and dietary and nutritional supplements
3 Non-medicated skin care preparations, namely creams, lotions, cleansers, moisturizers, astringents, emollients, exfoliators, sunscreens, mousses, toners, masks, powders, foundations, cosmetics, gels, pastes, roll-ons, patches, pads, tissues, wipes, antiperspirants, deodorants, nail polish, hair conditioners, shampoos, scalp treatments
5 Pharmaceutical preparations for the treatment of inflammatory and ischemic disorders, namely systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, autoimmune diabetes, skin inflammation including atopic dermatitis, contact dermatitis, allergic dermatisis, xerosis, eczema, rosacea, seborrhea, psoriasis, thermal and radiation burns, acne, oily skin, wrinkles, excessive cellulite, excessive pore size, intrinsic skin aging, photo aging, photo damage, harmful UV damage, keratinization abnormalities, alopecia, dyspigmentation inflammation due to wounds, scarring or stretch marks, loss of elasticity, skin atrophy, pigmentation control, psoriasis, inhibition of hair growth, inhibition of hair loss, stimulation of hair growth, gingivitis, central nervous system ischemia resulting from cardiac arrest, hypoxemia, transient ischemic attack, stroke or severe hypotension; cerebral ischemia including stroke, ischemic heart disease myocardial ischemia), spinal cord ischemia and paraplegia, retinal ischemia including age-related macular degeneration (ARMD), hepatic ischemia, renal ischemia, dermal ischemia, penile ischemia, pulmonary ischemia, gastric ischemia intestinal ischemia, splenic ischemia, pancreatic ischemia, skeletal muscle ischemia, ischemia associated with diabetic ulcers, gangrenous conditions, post-trauma syndrome, benign prostatic hyperplasia of hypertrophy (BPH), post prostate cancer surgery, cardiac arrest resuscitation, peripheral nerve damage or neuropathise, and dietary and nutritional supplements

ID: 1376354629